Patient Capital Management, based in Baltimore, released its first-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy,” available for download here. The strategy’s long-term value approach aims to build wealth over time. It returned -5.96% net of fees in Q1, compared to the S&P 500’s -4.33% return. As per three-factor performance attribution model the underperformance was due to selection and interaction effects, partly offset by allocation effects. The year started strongly with markets reaching an all-time high in late January, then reversed. AI fears sparked a “SaaS pocalypse,” while ‘hyperscalers’ CAPEX worries affected returns. Software debt and illiquid markets unsettled private credit, leading most BDCs to restrict redemptions. Middle East conflicts pushed crude oil prices higher, further increasing the risk of inflation. Please review the Strategy’s top five holdings to gain insights into their key selections for 2026.
In its first-quarter 2026 investor letter, Patient Opportunity Equity Strategy highlighted stocks like Chime Financial, Inc. (NASDAQ:CHYM). Chime Financial, Inc. (NASDAQ:CHYM) is a financial technology company that provides digital consumer banking and payment solutions. On April 10, 2026, Chime Financial, Inc. (NASDAQ:CHYM) closed at $19.61 per share. One-month return of Chime Financial, Inc. (NASDAQ:CHYM) was -3.64%, and YTD its shares lost 22.09% over the past 52 weeks. Chime Financial, Inc. (NASDAQ:CHYM) has a market capitalization of $7.53 billion.
Patient Opportunity Equity Strategy stated the following regarding Chime Financial, Inc. (NASDAQ:CHYM) in its Q1 2026 investor letter:
“Chime Financial, Inc. (NASDAQ:CHYM) was a top detractor during the first quarter, declining 25.5%. The sell-off reflects continued investor caution around fintech and consumer credit as the macro environment creates questions around credit quality. We continue to believe Chime is a differentiated and well-positioned business. As a newly public company, near-term volatility is not unexpected. The platform’s strong direct deposit-based model limits credit risk relative to peers, and the cross-sell opportunity within its existing engaged user base remains substantial. With a large and fragmented addressable market, improving product attach rates, and a clear path toward GAAP profitability, our long-term thesis on Chime remains intact. We view the current weakness as a reflection of near-term sentiment rather than any fundamental deterioration in the business.”
Chime Financial, Inc. (NASDAQ:CHYM) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 49 hedge fund portfolios held Chime Financial, Inc. (NASDAQ:CHYM) at the end of the fourth quarter, up from 39 in the previous quarter. While we acknowledge the risk and potential of Chime Financial, Inc. (NASDAQ:CHYM) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Chime Financial, Inc. (NASDAQ:CHYM) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Chime Financial, Inc. (NASDAQ:CHYM) and shared the list of best tech stocks under $50 to buy. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
